Press Releases Year None201920182017201620152014201320122011201020092008 Jan 24, 2019 Concert Pharmaceuticals Initiates Phase 1 Single-Ascending Dose Trial of CTP-692 as an Adjunctive Treatment for Schizophrenia Jan 22, 2019 Concert Pharmaceuticals Completes Enrollment of 12 mg Cohort in Phase 2a Trial of CTP-543 in Alopecia Areata Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Displaying 31 - 32 of 32
Jan 24, 2019 Concert Pharmaceuticals Initiates Phase 1 Single-Ascending Dose Trial of CTP-692 as an Adjunctive Treatment for Schizophrenia
Jan 22, 2019 Concert Pharmaceuticals Completes Enrollment of 12 mg Cohort in Phase 2a Trial of CTP-543 in Alopecia Areata
